Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study of Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Afatinib Genomic Landscape
- Status
- TERMINATED
- Phase
- N/A
Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC
- Status
- COMPLETED
- Phase
- NA
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC
- Status
- UNKNOWN
- Phase
- PHASE3
Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease
- Status
- TERMINATED
- Phase
- PHASE2
A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification
- Status
- TERMINATED
- Phase
- PHASE1
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1